Skip to search formSkip to main contentSkip to account menu

9cUAB30

Known as: (9Z)-UAB30, Retinoid 9cUAB30 
A synthetic analogue of 9-cis retinoic acid with potential antineoplastic and chemopreventive activities. Retinoid 9cUAB30 binds to and activates… 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

UAB 30

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Abstract LB-247: 9cis-retinoic UAB30 inhibits UVB-induced pro-inflammatory cytokines/chemokines signaling via targeting Bromodomain-4
BET bromodomain-containing protein 4 (BRD4), an epigenome reader works as an oncogene for several cancer types including those… 
2011
2011
Abstract 181: The combination of a novel retinoid compound with standard chemotherapy increases cytotoxicity in an ovarian cancer cell line
Background: Retinoids are a class of chemotherapeutic agents that have been studied in a variety of malignancies and are known to… 
2010
2010
A Pilot , First-inHuman , Pharmacokinetic Study of 9 cUAB 30 in Healthy Volunteers
9cUAB30 is a synthetic analog of 9-cis-retinoic acid with chemopreventive activity in cell lines and in animal models. The… 
2007
2007
In Vitro Metabolic Characterization, Phenotyping, and Kinetic Studies of 9cUAB30, a Retinoid X Receptor-Specific Retinoid
The present study was conducted to compare the in vitro phase I and phase II metabolic profiles of (2E,4E,6Z,8E)-8-(3′,4′-dihydro… 
2003
2003
9cUAB30, an RXR specific retinoid, and/or tamoxifen in the prevention of methylnitrosourea-induced mammary cancers.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)